XY8-12849-18619
5 vaccinations
3 coded responses
30 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 786 / TX
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-26
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
-
2021-10-08
Survey response — 6 month, dose 2MedDRA: Abdominal discomfort, Influenza like illness, SARS-CoV-2 test negative, Unevaluable event — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2021-12-06
Dose 3 — Pfizer-BioNTech
-
2022-04-08
Survey response — 12 month, dose 2MedDRA: Dyspnoea, Fatigue, Heart rate increased, Myalgia, Pain, Pre-existing disease, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2022-04-08
Report sent to call center — 12 month, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-20
-
2022-05-08
Dose 4 — Pfizer-BioNTech
-
2022-09-08
Dose 5 — Moderna
- 2022-10-08
- 2022-10-14
- 2022-10-20
-
2022-12-08
Survey response — 3 month, dose 5MedDRA: Glossodynia, Oral discomfort, Oral pain, Stomatitis, Tongue coated — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2022-12-08
Report sent to call center — 3 month, dose 5Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-09
Call successfulParticipant prefers to complete VAERS report online
-
2022-12-09
Call successfulParticipant prefers to complete VAERS report online
- 2023-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-12-06 | Pfizer-BioNTech | No |
| 4 | 2022-05-08 | Pfizer-BioNTech | No |
| 5 | 2022-09-08 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-08 | Successful 2022-12-09 |
Participant prefers to complete VAERS report online |
| 2022-12-08 | Successful 2022-12-09 |
Participant prefers to complete VAERS report online |
Free text
Release 10
Symptoms: Had flu like symptoms (ague, stomach upset etc). Got tested for COVID just to be safe and tested negative.
Release 11
Symptoms: Tested positive for COVID on March 18, 2022. Symptoms includes ague, muscle soreness, difficulty breathing, runny nose, fatigue, rapid heart rate but were milder than when I contracted it in March of 2020. Also shorter - 2 weeks instead of 4.
Release 12
Symptoms: Sore mouth - tongue and roof of mouth have have a grayish coating and is very sore as though I had scalded my mouth.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Glossodynia | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oral discomfort | · | · | ✓ |
| SD | Oral pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Stomatitis | · | · | ✓ |
| SD | Tongue coated | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release